Shares of food delivery platform DoorDash (NYSE: DASH) are creeping higher on Monday after it was announced that the company will begin facilitating same-day delivery of COVID-19 PCR test collection kits across the U.S through partnerships with Vault Health and Everlywell.
Consumers will be able to access two COVID-19 home collection kits that received FDA Emergency Use Authorization via on-demand delivery from DoorDash's DashMart locations.
The Vault Health COVID-19 Saliva Test Kit or Everlywell’s COVID-19 Test Home Collection Kit DTC will be available in 12 DashMart locations, including Baltimore, Chicago, Cleveland, Dallas, Denver, Minneapolis, and Phoenix, with more cities rolling out in the coming months.
They will also be available for same-day delivery through the DoorDash marketplace app or via Vault Health's website powered by DoorDash Drive, DoorDash's white-label fulfilment platform.
“We're proud to partner with Vault Health and Everlywell to provide FDA Authorized COVID-19 PCR test collection kits on-demand to customers through our marketplace for the first time, offering the speed and reliability Americans need in these circumstances,” said Anna Katherine Barnett-Hart, a Director at DoorDash.
DoorDash’s share price is currently trading at $136.43, following Friday’s close at $135.03.
Should You Invest in PayPal Shares?
One of the most frequently asked questions we receive is, “what stocks are best to buy right now?” It's a wide-ranging question, but one that we have answered… Our AskTraders stock analysts regularly review the market and compile a list of which companies you should be adding to your portfolio, including short and longer-term positions. Here are the best stocks to buy right now
